 |
Medical ResearchMedical data and research from Doctors Without Borders/Médecins Sans Frontières (MSF) field operations are regularly published in the peer-reviewed literature. Below is a selection of recently published MSF medical research articles. For copies or to search all MSF research publications, please visit the MSF Field Research website, or contact Dr. Patricia Kahn, Medical Editor, patricia.kahn[at]newyork.msf.org.
MSF research articles on Sleeping SicknessMay 26, 2011Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo
Jacqueline Tong, Olaf Valverde, Claude Mahoudeau, Oliver Yun, Francois Chappuis
February 1, 2010Human African trypanosomiasis in areas without surveillance [letter]
François Chappuis, Maria Angeles Lima, Laurence Flevaud, Koert Ritmeijer Central African Republic, Democratic Republic of the Congo, Sleeping Sickness
June 24, 2009Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto, Serena Kasparian, Wilfried Mutombo, Daniel Ngouama, Sara Ghorashian, Ute Arnold, Salah Ghabri, Elisabeth Baudin, Vincent Buard, Serge Kazadi-Kyanza, Médard Ilunga, Willy Mutangala, Gabriele Pohlig, Caecilia Schmid, Unni Karunakara, Els Torreele, Victor Kande Congo, Democratic Republic of the Congo, Neglected Diseases, Sleeping Sickness
October 22, 2008Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes
Manica Balasegaram, Heather Young, François Chappuis, Gerardo Priotto, Marie-Eve Raguenaud, Francesco Checchi
March 5, 2008Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: Cohort studyGerardo Priotto, Loretxu Pinoges, Isaac Badi Fursa, Barbara Burke, Nathalie Nicolay, Guillaume Grillet, Cathy Hewison, Manica Balasegaram
February 8, 2008Estimates of the duration of the early and late stage of gambiense sleeping sicknessFrancesco Checchi, Joao A.N. Filipe, Daniel T. Haydon, Daniel Chandramohan, Francois Chappuis
February 1, 2008Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, AngolaJ Robays, ME Raguenaud, T Josenando, M Boelaert
November 7, 2007Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: A case seriesFrancesco Checchi, Patrice Piola, Harriet Ayikoru, Florence Thomas, Dominique Legros, Gerardo Priotto
October 22, 2007Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: A randomized clinical trial in CongoGerardo Priotto et al.
|
86 cents of every dollar supports our programs. Subscribe to
|
|
|
|
||
